NCT02141022
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cognition Disorders, +9 more
- Locations
-
- Stony Brook University Stony Brook, New York, United States
Clinical trial condition
Gilenya Modifying Therapy for MS
Explore clinical trials studying Gilenya Modifying Therapy for MS. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies